InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: None

Monday, 03/06/2023 1:58:30 PM

Monday, March 06, 2023 1:58:30 PM

Post# of 572
A huge open question is whether we will see myelosuppression when TUSP is combined with Venetoclax. If we don't see it it will be a huge positive development. As I understand it the biggest hurdle doctor's are facing with using Quizartinib or Gilteritinib in combinations with VEN is myelosuppression.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News